US4263313A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Topical pharmaceutical formulations, carrier compositions therefor, and preparation thereof
Assignee: AbbVie Pharmaceuticals GmbH
•
Filing: 1978-02-22
•
Granted: 1981-04-21
•
Expires: 1998-02-22
Abstract
Abstract A carrier composition for cutaneously absorbable topical pharmaceutical formulations of pharmacologically active agents is disclosed which comprises at least one partial glyceride of a fatty acid of medium chain length. This vehicle enhances the permeation of the topical formulation through the skin. A topical formulation which comprises this permeation enhancing vehicle is suitable for cutaneously applying pharmacologically active agents which are locally and/or systematically effective in the body.
Inventors
- 👤 Theodor Eckert
- 👤 Fritz H. Kemper
- 👤 Martin Wischniewski
- 👤 Reinhard Hempel
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 12:21
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0014; A61K47/00; A61K47/06; A61K47/08; A61K47/14
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
115 words
In a topical pharmaceutical composition including a pharmacologically-effective amount of a pharmacologically-active agent distributed in a vehicle suitable for topical application to human and animal skin, wherein the pharmacologically-active agent comprises phenylbutazone, the improvement comprising said vehicle consisting essentially of an active-ingredient-absorption-enhancing amount of from about 20 to 100% by weight of a partial glyceride of a fatty acid of medium chain length selected from a monoglyceride or a diglyceride of a fatty acid containing from about 6 to about 12 carbon atoms or a mixture thereof, and from about 0 to 80% of one or more pharmaceutical adjuvants, whereby enhanced absorption of the active agent results upon application of the composition to the skin.
Claim 2
Dependent Claim
115 words
In a topical pharmaceutical composition including a pharmacologically-effective amount of a pharmacologically-active agent distributed in a vehicle suitable for topical application to human and animal skin, wherein the pharmacologically-active agent comprises phenylbutazone, the improvement comprising said vehicle consisting essentially of an active-ingredient-absorption-enhancing amount of from about 20 to 100% by weight of a partial glyceride of a fatty acid of medium chain length selected from a monoglyceride or a diglyceride of a fatty acid containing from about 6 to about 12 carbon atoms or a mixture thereof, and from about 0 to 80% of one or more pharmaceutical adjuvants, whereby enhanced absorption of the active agent results upon application of the composition to the skin.
Claim 3
Dependent Claim
29 words
A topical composition as defined in claim 1, wherein the vehicle comprises from about 40 to 100% of the partial glyceride of a fatty acid of medium chain length.
Claim 4
Dependent Claim
28 words
A topical composition as defined in claim 1, wherein the amount of the pharmacologically-active agent is from about 1 to about 10% by weight of the total composition.
Claim 5
Dependent Claim
29 words
A topical composition as defined in claim 1, wherein the weight ratio of pharmacologically-active agent to partial glyceride of a fatty acid is from about 1:5 to about 1:50.
Claim 6
Independent Claim
135 words
A method of enhancing the penetration through human and animal skin of a pharmacologically active agent comprising phenylbutazone and being capable of eliciting a physiological effect upon topical application thereof, which comprises the step of concurrently topically administering to the skin an amount of said active agent effective to produce the desired physiological effect and an amount of a vehicle consisting essentially of from about 20 to 100% by weight of a partial glyceride of a fatty acid of medium chain length selected from a monoglyceride or a diglyceride of a fatty acid containing from about 6 to about 12 carbon atoms or a mixture thereof, and from about 0 to 80% by weight of one or more pharmaceutical adjuvants, sufficient to effectively enhance penetration of said active agent to achieve the desired physiological result.
Claim 7
Independent Claim
135 words
A method of enhancing the penetration through human and animal skin of a pharmacologically active agent comprising phenylbutazone and being capable of eliciting a physiological effect upon topical application thereof, which comprises the step of concurrently topically administering to the skin an amount of said active agent effective to produce the desired physiological effect and an amount of a vehicle consisting essentially of from about 20 to 100% by weight of a partial glyceride of a fatty acid of medium chain length selected from a monoglyceride or a diglyceride of a fatty acid containing from about 6 to about 12 carbon atoms or a mixture thereof, and from about 0 to 80% by weight of one or more pharmaceutical adjuvants, sufficient to effectively enhance penetration of said active agent to achieve the desired physiological result.
Claim 8
Dependent Claim
27 words
A method according to claim 5, wherein the vehicle comprises from about 40 to 100% of the partial glyceride of a fatty acid of medium chain length.
Claim 9
Dependent Claim
25 words
A method according to claim 5, wherein the amount of the pharmacologically-active agent is from about 1 to 10% by weight of the total composition.
Claim 10
Dependent Claim
27 words
A method according to claim 5, wherein the weight ratio of pharmacologically-active agent to partial glyceride of a fatty acid is from about 1:5 to about 1:50.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-04-20 | 1984-10-20 | 1985-04-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-04-20 | 1988-10-20 | 1989-04-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-04-20 | 1992-10-20 | 1993-04-21 | $7700.00 | Window Closed / Lapsed |